SCHEMBL20832880

SCHEMBL20832880

Cc1cccc(OCc2nnc(-c3ccc(NC(=O)OC(C)(C)C)cn3)n2C)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.46
▸ RECQL P46063 1/20 0.46
▸ KMT2A Q03164 2/20 0.44
▸ PPARG P37231 1/20 0.43
▸ NR2E3 Q9Y5X4 1/20 0.43
▸ NCOR2 Q9Y618 1/20 0.43
▸ RORC P51449 1/20 0.42
▸ PKM P14618 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ TSHR P16473 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SIRT2 Q8IXJ6 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20828522 0.90 RAB9A (0.43) MAPTKMT2APPARGRORCMEN1
SCHEMBL20828305 0.90 SIRT2 (0.37) MAPTRECQLKMT2APPARGNR2E3
SCHEMBL30234297 0.90 SIRT2 (0.37) MAPTRECQLKMT2APPARGNR2E3
SCHEMBL30602664 0.90 SIRT2 (0.37) MAPTRECQLKMT2APPARGNR2E3
SCHEMBL20832631 0.78 MAOA (0.44) PPARGRORCSIRT2MAOAMAOB
SCHEMBL22623093 0.76 NPC1 (0.47) MAPTRECQLKMT2APPARGNR2E3
SCHEMBL20832678 0.72 PPARG (0.55) MAPTRECQLKMT2APPARGNR2E3
SCHEMBL20828440 0.72 MAOA (0.42) MAPTKMT2APPARGMEN1MAOA
SCHEMBL9237307 0.71 CYP17A1 (0.48) —
SCHEMBL22237409 0.71 L3MBTL1 (0.43) KMT2APPARGRORCMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331700-A1 COMPOUND HAVING CYCLIC STRUCTURE DAIICHI SANKYO COMPANY, LIMITED (JP) 2023-10-19 — — US disclosed
US-20200347030-A1 COMPOUND HAVING CYCLIC STRUCTURE DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-11-05 — — US disclosed
EP-3682881-A1 COMPOUND HAVING CYCLIC STRUCTURE DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-07-22 — — EP disclosed
WO-2019054427-A1 COMPOUND HAVING CYCLIC STRUCTURE 第一三共株式会社 2019-03-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200347030-A1 COMPOUND HAVING CYCLIC STRUCTURE H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ECE1, IL1B MAPT 3883/4885RECQL 1194/4885KMT2A 1805/4885
US-20230331700-A1 COMPOUND HAVING CYCLIC STRUCTURE H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ECE1, IL1B MAPT 3883/4885RECQL 1194/4885KMT2A 1805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback